Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
218.04
-10.16 (-4.45%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
Red Spruce Capital Dumps 35K SouthState Bank (SSB) Shares Worth $3.2 Million
October 07, 2025
Via
The Motley Fool
Topics
Credit Cards
Regulatory Compliance
3 Dividend Stocks to Double Up On Right Now
October 07, 2025
The time is right for buying more of these great dividend stocks.
Via
The Motley Fool
Topics
Economy
Energy
3 Exceptional Stocks to Build Long-Term Wealth
October 06, 2025
Discover three standout growth stocks with strong long-term potential, spanning space, retail, and biotech industries, poised for sustained investor returns
Via
MarketBeat
Topics
Economy
AbbVie's Botox Shows Improvement In Movement Disorder Study
October 06, 2025
AbbVie's Phase 2 ELATE trial shows onabotulinumtoxinA improves tremor scores and meets all endpoints, offering a new option for essential tremor.
Via
Benzinga
What Does the Market Think About AbbVie Inc?
October 03, 2025
Via
Benzinga
A Closer Look at AbbVie's Options Market Dynamics
September 30, 2025
Via
Benzinga
St Louis Financial Loads Up on AbbVie (ABBV) With 14,600 Shares Buy
October 03, 2025
Via
The Motley Fool
Topics
Intellectual Property
2 Healthcare Stocks to Research Further and 1 Facing Challenges
October 03, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...
Via
StockStory
Topics
Stocks
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
October 02, 2025
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
These S&P500 stocks are gapping in today's session
October 02, 2025
Stay tuned for the market movements in the S&P500 index on Thursday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Via
Chartmill
Why AbbVie Stock Cruised to an Almost 6% Gain Today
October 01, 2025
A new expansion project and a win for a peer pharmaceutical company were attracting investors to the shares.
Via
The Motley Fool
Topics
Government
World Trade
Healthcare Sector Defies Headwinds, Rallies on Wall Street Amidst Shutdown and Jobs Data
October 01, 2025
New York, NY – October 1, 2025 – In a surprising turn of events on Wall Street today, the healthcare sector emerged as the undisputed leader, shrugging off the dual anxieties of a U.S. government...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Why AbbVie (ABBV) Stock Is Trading Up Today
October 01, 2025
Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 5.2% in the afternoon session after the company submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA)...
Via
StockStory
Topics
Government
World Trade
10 Health Care Stocks Whale Activity In Today's Session
October 01, 2025
Via
Benzinga
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
October 01, 2025
If you are looking for dividend stocks that can provide a reliable, long-term income stream, consider buying AbbVie, Coca-Cola, and Chevron.
Via
The Motley Fool
Topics
Intellectual Property
U.S. Drug Pricing Reforms Send Ripples Across Global Healthcare Sector
September 30, 2025
The global healthcare sector is currently navigating a period of profound transformation, driven by aggressive regulatory changes emanating from the United States. As of late September 2025, a series...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
September 30, 2025
New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a...
Via
MarketMinute
Topics
Government
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
September 30, 2025
Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing...
Via
MarketMinute
Topics
Economy
Government
World Trade
AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know
September 30, 2025
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.
Via
StockStory
Topics
Government
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever
September 29, 2025
Dividend stocks can be a more predictable stream of income for investors.
Via
The Motley Fool
Topics
ETFs
Stocks
Here's How Much $100 Invested In AbbVie 5 Years Ago Would Be Worth Today
September 29, 2025
AbbVie (NYSE: ABBV) has outperformed the market over the past 5 years by 6.25% on an annualized basis producing an average annual return of 20.98%. Currently, AbbVie has a market capitalization of...
Via
Benzinga
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
September 29, 2025
The U.S. pharmaceutical industry is at the center of a policy maelstrom.
Via
Benzinga
Topics
ETFs
1 Top ETF I Wouldn't Hesitate to Invest $1,000 Into Right Now
September 29, 2025
This fund makes it easy to invest in the top dividend stocks.
Via
The Motley Fool
Topics
ETFs
Stocks
Why the Schwab U.S. Dividend Equity ETF Could Be a Top Choice for Dividend Investors in 2025
September 28, 2025
Instead of choosing just one or two stocks, buy a bunch of quality dividend-payers with a single ETF.
Via
The Motley Fool
Topics
ETFs
Stocks
5 Dividend Powerhouses to Buy and Never Sell
September 28, 2025
These blue-chip giants have paid shareholders through wars, recessions, and pandemics.
Via
The Motley Fool
Topics
Intellectual Property
Major Insider Sale Casts Shadow on LENZ Therapeutics' Valuation
September 27, 2025
San Diego, CA – September 27, 2025 – LENZ Therapeutics (NASDAQ: LENZ) is facing heightened scrutiny this week following a significant insider share sale by a major shareholder, Versant Venture Capital...
Via
MarketMinute
Topics
Artificial Intelligence
NEXGEL Inc. Equity Warrants: A High-Stakes Bet on Future Profitability Amidst Rapid Growth
September 27, 2025
Langhorne, PA – September 27, 2025 – Investors in NEXGEL Inc. (NASDAQ: NXGL), a company at the forefront of hydrogel technology, are closely watching the trajectory of its equity warrants (NXGLW)....
Via
MarketMinute
Topics
Intellectual Property
Decoding AbbVie's Options Activity: What's the Big Picture?
September 26, 2025
Investors with a lot of money to spend have taken a bearish stance on AbbVie (NYSE: ABBV). And retail traders should know. We noticed this today when the trades showed up on publicly available options...
Via
Benzinga
Pharma Tariffs Back In Spotlight On New Trump Threat
September 26, 2025
President Donald Trump threatened 100% tariffs on some drug imports.
Via
Investor's Business Daily
Topics
ETFs
Government
World Trade
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.